Clinical observation of sunitinib as second-line treatment for Chinese patients with recurrent or metastatic gastrointestinal stromal tumor

LIU Xiufeng; QIN Shukui; WANG Lin; CHEN Yingxia; HUA Haiqing; GONG Xinlei; CAO Mengran

doi:10.3969/j.issn.1009-0460.2013.07.014

Home>Articles>Clinical observation of sunitinib as second-line treatment for Chinese patients with recurrent or metastatic gastrointestinal stromal tumor

DOI: 10.3969/j.issn.1009-0460.2013.07.014

Clinical observation of sunitinib as second-line treatment for Chinese patients with recurrent or metastatic gastrointestinal stromal tumor

LIU Xiufeng

QIN Shukui

WANG Lin

CHEN Yingxia

HUA Haiqing

GONG Xinlei

CAO Mengran

Keywords：SunitinibImatinibGastrointestinal stromal tumorSurvival analysis

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 636-639 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2013,18(7)